Bradykinin B2 Receptor Antagonist Off Label Use in Short-Term Prophylaxis in Hereditary Angioedema

International Journal of Immunopathology and Pharmacology - Italy
doi 10.1177/039463201402700423
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Successful C1 Inhibitor Short-Term Prophylaxis During Redo Mitral Valve Replacement in a Patient With Hereditary Angioedema

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2010English

Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis

New England Journal of Medicine
Medicine
2017English

Changes in Bradykinin and Bradykinin B2-Receptor During Estrous Cycle of Mouse

Acta Histochemica
MedicineHistologyCell Biology
2011English

Effects of Hoe 140, a Bradykinin B2-Receptor Antagonist, on Renal Function in Conscious Normotensive Rats

British Journal of Pharmacology
Pharmacology
1992English

Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long-Term Prophylaxis: Interim Results From the HELP Open-Label Extension Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Effects of WIN 64338, a Nonpeptide Bradykinin B2 Receptor Antagonist, on Guinea-Pig Trachea

British Journal of Pharmacology
Pharmacology
1995English

Long-Term Prophylaxis With Recombinant Human C1 Inhibitor in Patients With Hereditary Angioedema: Is Intramuscular Administration an Option?

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Expression Cloning of a Rat B2 Bradykinin Receptor.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1991English

Bradykinin and B2 Receptor Antagonism in Rat and Human Articular Chondrocytes

British Journal of Pharmacology
Pharmacology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy